OUR VISION IS TO
Unlock the microbiome to
change the world of medicine

Kaleido Biosciences, Inc. is a clinical-stage biotech company with a differentiated, small molecule approach to treating inflammatory conditions and diseases by selectively targeting the resident microbiome to restore gut-immune homeostasis.
icon1

Unique, Chemistry-Driven Approach

Developing novel Microbiome Metabolic Therapies (MMT™) to drive functional outputs of the microbiome

Learn more about MMTs

icon2

Discovery & Development Model

Enables rapid advancement into human clinical studies

Learn about our proprietary product platform

icon3

Broad Pipeline

Candidates addressing a variety of diseases and conditions with high unmet needs

View our pipeline

icon4

Exceptional Team

Committed to scientific innovation, transforming lives and fostering a strong culture

Join the team